Why does targeted temperature management (TTM) for post-cardiac arrest patients prevent fever above a specified range, such as 32-36°C, after the initial cooling phase?

💡 Explanation

TTM aims to prevent secondary brain injury by tightly controlling body temperature via hypothalamic set-point modulation. Because the hypothalamus acts as the body’s thermostat, its set-point must be lowered and maintained to prevent shivering and fever. Therefore, the hypothalamic thermoregulatory set-point is reset, rather than inducing permanent vasoconstriction or completely inhibiting cytokine production.

• Why does bone mineral density reduce more drastically in the femoral neck compared to the lumbar spine under prolonged microgravity conditions?
• A patient with rheumatoid arthritis takes a TNF-alpha inhibitor. Which consequence becomes likely due to this immunosuppression?
• If an elderly individual experiences increased oxidative stress in their skeletal muscle cells due to reduced antioxidant enzyme activity, which consequence is most likely?
• If a patient lacks intrinsic factor production in their stomach, which consequence affecting digestive processes is most likely?
• A patient with kidney disease has impaired countercurrent multiplier function. What happens to urine osmolality as fluid moves through the collecting duct?
• Why does performance on cognitive tasks requiring memorization suffer more after sleep deprivation compared to tasks requiring simple reaction time?